mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.02 |
mRNA |
AZD1480 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.02 |
mRNA |
BRD-K14844214 |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.02 |
mRNA |
prochlorperazine |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.02 |
mRNA |
Methotrexate |
FIMM |
pan-cancer |
AAC |
-0.29 |
0.02 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.03 |
mRNA |
SCH-529074 |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.03 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.03 |
mRNA |
erastin |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.03 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.03 |